Register for free to listen to this article
Listen with Speechify
0:00
2:00
SAN DIEGO—Assay Depot and Rare Genomics Institute announcedOct. 15 that they have partnered with 19 life science companies to launch thefirst Rare Disease Science Challenge: Helping Empower and Accelerate ResearchDiscoveries, or "Be HEARD."  
The hosts and sponsoring organizations are supporting raredisease research by donating $400,000 in cutting edge technology, services andresources, as well as a $10,000 cash prize to the winning research proposal.
 
Be HEARD encourages non-profits, academic researchers, raredisease advocacy groups, families of rare disease patients and for-profitcompanies to collaborate to advance rare disease research.
 
"This competition brings the life science community togetherto study rare diseases in an unprecedented opportunity to empower afflictedfamilies and underfunded researchers," says Kevin Lustig, CEO of Assay Depot."Ultimately, we want the voices of rare disease to be heard, while helping toaccelerate the science behind a cure."
 
 
Research proposals can be submitted from until Dec. 15 forany or all of the nearly 20 donated services. An expert scientific panel willselect the winner for each donation. 
 
 
For more information, visit http://challenge.assaydepot.com/rare-disease-challenge.
 

Other sponsors of Be HEARD include Biopta, Charles RiverLaboratories, DNA Software, HistoRx, Ingenuity Systems and Taconic. Mediapartners include Ben's Friends, DrugDiscovery News, Drug Discovery and Development, Global Genes R.A.R.E.Project, Global Healthy Living Foundation and Mendelspod
 


"We are amazed by the generosity of so many companiesoffering their expertise, services, consulting and reagents to help advancerare disease research," says Jimmy Lin, President of Rare Genomics Institute."We hope this gives a boost to rare diseases research and jump starts researchin diseases that are otherwise not studied."

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue